Patents by Inventor Warren Starkebaum
Warren Starkebaum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8600495Abstract: Apparatus and techniques to address problems associated with lead migration, patient movement or position, histological changes, neural plasticity or disease progression. Disclosed are techniques for implanting a lead having therapy delivery elements, such as electrodes or drug delivery ports, within a vertebral or cranial bone so as to maintain these elements in a fixed position relative to a desired treatment site. The therapy delivery elements may thereafter be adjusted in situ with a position control mechanism and/or a position controller to improve the desired treatment, such as electrical stimulation and/or drug infusion to a precise target. The therapy delivery elements may be positioned laterally in any direction relative to the targeted treatment site or toward or away from the targeted treatment site. A control system maybe provided for open- or closed-loop feedback control of the position of the therapy delivery elements as well as other aspects of the treatment therapy.Type: GrantFiled: June 4, 2010Date of Patent: December 3, 2013Assignee: Medtronic, Inc.Inventors: Frans Gielen, Gary W. King, Daryle Petersen, Mark T. Rise, Michael Schendel, Warren Starkebaum
-
Publication number: 20120259389Abstract: In some examples, the disclosure relates to a systems, devices, and techniques for delivering electrical stimulation therapy to a patient. In some example, the disclosure relates to systems and methods of treating hyperglycemia in a patient including delivering gastric electrical stimulation (GES) to the patient. Devices, systems and methods according to the disclosure may comprise an implantable stimulator, a blood glucose monitor and/or a food intake sensor. In some examples, a blood glucose level and/or food intake of a patient is detected and GES is delivered to the patient in response to the detection.Type: ApplicationFiled: April 12, 2012Publication date: October 11, 2012Inventors: Warren Starkebaum, John E. Burnes, Roland C. Maude-Griffin
-
Publication number: 20100241179Abstract: Apparatus and techniques to address problems associated with lead migration, patient movement or position, histological changes, neural plasticity or disease progression. Disclosed are techniques for implanting a lead having therapy delivery elements, such as electrodes or drug delivery ports, within a vertebral or cranial bone so as to maintain these elements in a fixed position relative to a desired treatment site. The therapy delivery elements may thereafter be adjusted in situ with a position control mechanism and/or a position controller to improve the desired treatment, such as electrical stimulation and/or drug infusion to a precise target. The therapy delivery elements may be positioned laterally in any direction relative to the targeted treatment site or toward or away from the targeted treatment site. A control system maybe provided for open- or closed-loop feedback control of the position of the therapy delivery elements as well as other aspects of the treatment therapy.Type: ApplicationFiled: June 4, 2010Publication date: September 23, 2010Applicant: Medtronic, Inc.Inventors: Frans Gielen, Gary W. King, Daryle Petersen, Mark T. Rise, Michael Schendel, Warren Starkebaum
-
Patent number: 7734342Abstract: Apparatus and techniques to address problems associated with lead migration, patient movement or position, histological changes, neural plasticity or disease progression. Disclosed are techniques for implanting a lead having therapy delivery elements, such as electrodes or drug delivery ports, within a vertebral or cranial bone so as to maintain these elements in a fixed position relative to a desired treatment site. The therapy delivery elements may thereafter be adjusted in situ with a position control mechanism and/or a position controller to improve the desired treatment, such as electrical stimulation and/or drug infusion to a precise target. The therapy delivery elements may be positioned laterally in any direction relative to the targeted treatment site or toward or away from the targeted treatment site. A control system maybe provided for open- or closed-loop feedback control of the position of the therapy delivery elements as well as other aspects of the treatment therapy.Type: GrantFiled: January 31, 2007Date of Patent: June 8, 2010Assignee: Medtronics, Inc.Inventors: Frans Gielen, Gary W. King, Daryle Petersen, Mark T. Rise, Michael Schendel, Warren Starkebaum
-
Publication number: 20070282387Abstract: The disclosure is directed to techniques for delivering electrical stimulation therapy to support obesity management. The electrical stimulation therapy is configured to cause at least partial gastric distention. Gastric distention tends to induce a sensation of fullness and thereby discourages excessive food intake by the patient. The electrical stimulation therapy may be delivered to the gastrointestinal tract of the patient by electrodes deployed by one or more implantable leads coupled to an electrical stimulator. The electrical stimulator delivers stimulation pulses having a pulse width in a range found to be effective in causing gastric distention.Type: ApplicationFiled: May 17, 2007Publication date: December 6, 2007Applicant: Medtronic, Inc.Inventor: Warren Starkebaum
-
Publication number: 20070255336Abstract: This disclosure describes an implantable medical device that delivers electrical stimulation to a patient in combination with limiting ingestion of food by the patient to treat obesity. The device includes a gastric constriction device, such as a hydraulic or electro-mechanical gastric band, having a plurality of electrodes integrally formed thereon. One or more of the electrodes, i.e., an electrode combination, are selected to deliver electrical stimulation energy, e.g., in the form of stimulation pulses, to the patient. The electrode combination may deliver pulses in accordance with various modes, e.g., continuously, in a series of bursts, or a combination of both. When more than one electrode combination is selected, each electrode combination may deliver pulses in accordance with a different set of stimulation parameters. The electrode combinations may deliver pulses at the same time or on a time-interleaved basis.Type: ApplicationFiled: April 28, 2006Publication date: November 1, 2007Applicant: Medtronic, Inc.Inventors: Timothy Herbert, Warren Starkebaum
-
Publication number: 20070255295Abstract: A device comprises a medical implant and an actively deployable clip attached to the medical implant that operates to restrict movement of the medical implant once the actively deployable clip is deployed within a body of a patient. In some embodiments, the medical implant is an electrical lead for electrical stimulation. The actively deployable clip is operable to fixate the medical implant to a body tissue once deployed, such that the actively deployable clip performs a similar function to a suture. In this manner, embodiments of the invention may provide a medical implant that requires few or even no sutures to properly fixate the implant within the patient.Type: ApplicationFiled: April 27, 2006Publication date: November 1, 2007Applicant: Medtronic, Inc.Inventors: Warren Starkebaum, Daniel Stetson, Eric Bonde
-
Publication number: 20070255335Abstract: This disclosure describes an implantable medical device that delivers electrical stimulation to a patient in combination with restriction ingestion of food by the patient to treaty obesity. The implantable medical device includes a gastric constriction device, such as a hydraulic or mechanical gastric band having a plurality of electrodes integrally formed thereon. A controller includes a control unit to control the degree of gastric constriction of the gastric constriction device and a pulse generator to control delivery of electrical stimulation to the patient. The control unit and pulse generator are enclosed within a housing implanted within the patient. By enclosing the control unit and pulse generator within a common housing, the trauma experienced by the patient during the implantation procedure may be substantially reduced. Additionally, the cost of the controller may be less than the cost of purchasing a control unit and a pulse generator separately.Type: ApplicationFiled: April 28, 2006Publication date: November 1, 2007Applicant: Medtronic, Inc.Inventors: Timothy Herbert, Warren Starkebaum
-
Publication number: 20070255334Abstract: Techniques are described that allow an implantable device to sense gastric data and activity data from a patient, and estimate the patient's amount of energy consumed and energy expended based on the sensed data. A system provides feedback to the patient, a family member, or a doctor about the patient's energy consumed, energy expended, and net energy. The data may be provided in table or graphical format, and may show daily or weekly energy balance data or may show a trend of the daily or weekly energy data. The patient may receive feedback by an implanted alert module that provides and audio alert or a vibration alert. In addition, data acquired by the system may be used to adjust the patient's stimulation therapy parameters.Type: ApplicationFiled: April 28, 2006Publication date: November 1, 2007Applicant: Medtronic, Inc.Inventors: John Keimel, Warren Starkebaum, Gary Lubben
-
Publication number: 20070203531Abstract: Methods and systems for stimulating a gastrointestinal system and for modifying a stimulation signal based on an indicator of autonomic nervous system function are described. One indicator of autonomic nervous system described is cardiac activity, including heart rate variability. Methods for selecting candidate patients for gastrointestinal stimulation therapy based on an indicator of autonomic nervous system function and methods of treating patients at risk of or suffering from gastrointestinal disorders by modifying therapy based on an indicator of autonomic function are also discussed.Type: ApplicationFiled: April 30, 2004Publication date: August 30, 2007Applicant: Medtronic, Inc.Inventor: Warren Starkebaum
-
Publication number: 20070123954Abstract: Apparatus and techniques to address problems associated with lead migration, patient movement or position, histological changes, neural plasticity or disease progression. Disclosed are techniques for implanting a lead having therapy delivery elements, such as electrodes or drug delivery ports, within a vertebral or cranial bone so as to maintain these elements in a fixed position relative to a desired treatment site. The therapy delivery elements may thereafter be adjusted in situ with a position control mechanism and/or a position controller to improve the desired treatment, such as electrical stimulation and/or drug infusion to a precise target. The therapy delivery elements may be positioned laterally in any direction relative to the targeted treatment site or toward or away from the targeted treatment site. A control system maybe provided for open- or closed-loop feedback control of the position of the therapy delivery elements as well as other aspects of the treatment therapy.Type: ApplicationFiled: January 31, 2007Publication date: May 31, 2007Applicant: Medtronic, Inc.Inventors: Frans Gielen, Gary King, Daryle Petersen, Mark Rise, Michael Schendel, Warren Starkebaum
-
Publication number: 20070098754Abstract: Method and article for restoring function to a region of a body selected from the group consisting of a gastrointestinal tract and a urinary tract of a patient. A biological agent is optionally associated with a carrier and inserted into the region of the body. The biological agent is stabilized in the region of the body. The biological agent is selected from a group consisting of nerve cells, interstitial cells of Cajal, stem cells and combinations thereof.Type: ApplicationFiled: October 28, 2005Publication date: May 3, 2007Inventors: Yelena Tropsha, Warren Starkebaum
-
Publication number: 20070098798Abstract: Article and method of restoring function to a flow control location in a patient. A biological agent is inserted into a region near the flow control location. The biological agent is stabilized in the region. The biological agent is a biological agent selected from a group consisting of growth factors, fibroblast cells, smooth muscle cells, endothelial cells, stem cells and combinations thereof.Type: ApplicationFiled: October 28, 2005Publication date: May 3, 2007Inventors: Yelena Tropsha, Warren Starkebaum
-
Patent number: 7191018Abstract: Apparatus and techniques to address the problems associated with lead migration, patient movement or position, histological changes, neural plasticity or disease progression. Disclosed are techniques for implanting a lead having therapy delivery elements, such as electrodes or drug delivery ports, within a vertebral or cranial bone so as to maintain these elements in a fixed position relative to a desired treatment site. The therapy delivery elements may thereafter be adjusted in situ with a position control mechanism and/or a position controller to improve the desired treatment, such as_electrical stimulation and/or drug infusion to a precise target. The therapy delivery elements may be positioned laterally in any direction relative to the targeted treatment site or toward or away from the targeted treatment site. A control system maybe provided for open- or closed-loop feedback control of the position of the therapy delivery elements as well as other aspects of the treatment therapy.Type: GrantFiled: June 30, 2004Date of Patent: March 13, 2007Assignee: Medtronic, Inc.Inventors: Frans Gielen, Gary W. King, Daryle Petersen, Mark T. Rise, Michael Schendel, Warren Starkebaum
-
Publication number: 20060265021Abstract: An intra-luminal device for gastrointestinal electrical stimulation is self-powered and self-contained within a capsule-like housing, and is capable of non-surgical implantation within the patient. The device includes an implantable pulse generator and one or more electrodes mounted within a common device housing. The device housing is capable of endoscopic introduction to a desired location within the gastrointestinal tract, such as the stomach, via the esophagus. The device may be appropriate for short-term, mid-term or trial stimulation applications.Type: ApplicationFiled: April 24, 2006Publication date: November 23, 2006Applicant: Medtronic, Inc.Inventors: Timothy Herbert, Warren Starkebaum
-
Publication number: 20060257445Abstract: A bulking device for implantation into a lumen wall that includes a bulking material that is configured to alter the portion of the lumen into which it is implanted and one or more therapeutic substances in association with the bulking material, wherein the device is configured to alter the portion of the lumen wall into which it is implanted. A method for inserting devices of the invention are also included.Type: ApplicationFiled: April 29, 2005Publication date: November 16, 2006Applicant: Medtronic, Inc.Inventors: Yelena Tropsha, Warren Starkebaum
-
Publication number: 20060257446Abstract: A bulking device for implantation into a lumen wall that includes a bulking material that is configured to alter the portion of the lumen into which it is implanted and one or more therapeutic substances in association with the bulking material, wherein the device is configured to alter the portion of the lumen wall into which it is implanted. A method for inserting devices of the invention are also included.Type: ApplicationFiled: April 29, 2005Publication date: November 16, 2006Applicant: Medtronic, Inc.Inventors: Yelena Tropsha, Warren Starkebaum
-
Publication number: 20060257444Abstract: A bulking device for implantation into a lumen wall that includes a bulking material that is configured to alter the portion of the lumen into which it is implanted and one or more therapeutic substances in association with the bulking material, wherein the device is configured to alter the portion of the lumen wall into which it is implanted. A method for inserting devices of the invention are also included.Type: ApplicationFiled: April 29, 2005Publication date: November 16, 2006Applicant: Medtronic, Inc.Inventors: Yelena Tropsha, Warren Starkebaum
-
Publication number: 20060247720Abstract: A stimulation device for electrical stimulation of a target location of a gastrointestinal tract of a patient that includes a device housing sized for introduction into a gastrointestinal tract, wherein the device housing is configured to attach to a connector, an electrical pulse generator, mounted within the device housing, to generate an electrical stimulation waveform, one or more electrodes electrically coupled to the electrical pulse generator and mounted to the device housing to deliver the electrical stimulation waveform to the gastrointestinal tract, and a fixation structure to attach the device housing to the target location of the gastrointestinal tract, wherein the stimulation device is configured to be tethered to an area around the target location using the connector.Type: ApplicationFiled: April 29, 2005Publication date: November 2, 2006Applicant: Medtronic, Inc.Inventor: Warren Starkebaum
-
Publication number: 20060247768Abstract: A method for treatment of obesity involves implantation of bulking devices within the upper esophageal sphincter (UES) to inhibit swallowing, thereby limiting food intake and treating obesity. One or more bulking devices are implanted within or near the UES to create a partial obstruction, partially impair UES muscle function, or both. The bulking devices make swallowing difficult, limiting the rate of food intake by a patient, and discouraging the patient from quickly consuming an excessive amount of food at one time.Type: ApplicationFiled: April 28, 2005Publication date: November 2, 2006Applicant: Medtronic, Inc.Inventor: Warren Starkebaum